Rchr
J-GLOBAL ID:201801007498052099   Update date: Sep. 20, 2024

Ishii Kenichiro

イシイ ケンイチロウ | Ishii Kenichiro
Affiliation and department:
Job title: Professor
Other affiliations (1):
Homepage URL  (1): https://www.nuas.ac.jp/profile/staff/nursing.html
Research field  (5): Pharmacology ,  Tumor biology ,  Experimental pathology ,  Urology ,  Digestive surgery
Research keywords  (5): ドラッグ・リポジショニング ,  がん微小環境 ,  線維芽細胞 ,  前立腺がん ,  膵臓がん
Research theme for competitive and other funds  (30):
  • 2022 - 2025 Functional analysis of primary cilia in the prostate cancer microenvironment and diagnostic and therapeutic strategies
  • 2022 - 2025 Development of a novel histopathological examination method for castration-resistant prostate cancer focusing on neutral theory of molecular evolution
  • 2020 - 2023 膵癌における一次線毛の機能異常と臨床病理学的特性との連関
  • 2021 - 2022 前立腺がん組織における一次線毛動態を指標にした個別化ホルモン療法の開発
  • 2019 - 2022 泌尿器腫瘍の診断・治療のための生体膜修飾で拓くナノキャリアのプラットホーム作製
Show all
Papers (53):
  • Naoki Tsunokuma, Doris Narki Tetteh, Kana Isono, Mari Kuniishi-Hikosaka, Motokazu Tsuneto, Kenichiro Ishii, Hidetoshi Yamazaki. Depletion of Neural Crest-Derived Cells Leads to Plasma Noradrenaline Decrease and Alters T Cell Development. Journal of immunology (Baltimore, Md. : 1950). 2023
  • Chise Matsuda, Kenichiro Ishii, Yasuhisa Nakagawa, Taku Shirai, Takeshi Sasaki, Yoshifumi S Hirokawa, Kazuhiro Iguchi, Masatoshi Watanabe. Fibroblast-derived exosomal microRNA regulates NKX3-1 expression in androgen-sensitive, androgen receptor-dependent prostate cancer cells. Journal of cellular biochemistry. 2023. 124. 8. 1135-1144
  • Kenichiro Ishii, Yoshiki Sugimura, Masatoshi Watanabe. Drug Repositioning of the Phenylpiperazine Derivative Naftopidil in Prostate Cancer Treatment. Biomedical Translational Research. 2022. 111-120
  • Kenichiro Ishii, Yasuhisa Nakagawa, Chise Matsuda, Daisuke Katoh, Masako Ichishi, Taku Shirai, Yoshifumi Hirokawa, Masaya Fujiwara, Yoshiki Sugimura, Masatoshi Watanabe. Heterogeneous induction of an invasive phenotype in prostate cancer cells by coculturing with patient-derived fibroblasts. Journal of cellular biochemistry. 2021. 122. 6. 679-688
  • Yoshifumi S Hirokawa, Kazuki Kanayama, Michiko Kagaya, Naoshi Shimojo, Katsunori Uchida, Hiroshi Imai, Kenichiro Ishii, Masatoshi Watanabe. SOX11-induced decrease in vimentin and an increase in prostate cancer cell migration attributed to cofilin activity. Experimental and molecular pathology. 2020. 117. 104542-104542
more...
MISC (31):
more...
Patents (1):
  • チューブリン重合阻害剤としてのフェニルピペラジン誘導体
Lectures and oral presentations  (82):
  • 癌抑制性CAFsは前立腺癌細胞におけるNKX3-1のアップレギュレーションを標的とする可溶性因子を産生する
    (日本癌学会総会記事 2021)
  • 前立腺癌細胞におけるCofilin活性化に関わる因子
    (日本病理学会会誌 2021)
  • SOX11による前立腺癌細胞の浸潤、運動能亢進機構
    (日本病理学会会誌 2020)
  • Loss of fibroblasts-dependent androgen receptor activation in prostate cancer cells develops castration-resistant prostate cancer
    (CANCER RESEARCH 2019)
  • チロシンキナーゼ阻害剤、ニロチニブによる前立腺癌細胞に対するオフターゲット効果
    (日本泌尿器科学会総会 2019)
more...
Education (3):
  • 1998 - 2001 Gifu Pharmaceutical University Graduate School Department of Pharmaceutical Science
  • 1996 - 1998 Gifu Pharmaceutical University Graduate School Department of Pharmaceutical Science
  • 1992 - 1996 Gifu Pharmaceutical University Faculty of Pharmaceutical Science Department of Public Health Pharmacy
Professional career (2):
  • Ph.D. (Gifu Pharmaceutical University)
  • Ph.D. (Mie University)
Work history (10):
  • 2024/04 - 現在 Mie University Department of Oncologic Pathology, Graduate School of Medicine Research associate/Visiting Professor
  • 2024/04 - 現在 Nagoya University of Arts and Sciences Department of Nursing, Graduate School of Nursing Professor
  • 2023/04 - 2024/03 Nagoya University of Arts and Sciences Department of Nursing, Graduate School of Nursing Associate Professor
  • 2021/04 - 2024/03 Mie University Department of Oncologic Pathology, Graduate School of Medicine Research associate/Visiting Associate Professor
  • 2021/04 - 2023/03 Nagoya University of Arts and Sciences Department of Nursing Associate Professor
Show all
Committee career (4):
  • 2019/04 - 現在 New Energy and Industrial Technology Development Organization Written judge
  • 2020/11 - 2023/10 独立行政法人日本学術振興会 令和2・3・4年度科学研究費助成事業「2段階書面審査 基盤研究C 泌尿器科学関連」専門委員会
  • 2015/10 - 2017/09 独立行政法人日本学術振興会 平成27・28年度科学研究費助成事業「腫瘍生物学」専門委員会
  • 2013/10 - 2014/09 文部科学省 平成25年度新学術領域研究「性差」専門委員会
Awards (7):
  • 2018/12 - 公益財団法人 三重医学研究振興会 緑の風記念三重医学研究振興会賞(基礎医学部門)
  • 2016/09 - 独立行政法人日本学術振興会 平成28年度科学研究費助成事業審査委員の表彰
  • 2010/02 - 第10回 AKUA (Asahi Kasei pharma Urological Academy) 泌尿器科研究奨励賞
  • 2009/04 - The 2009 American Urological Association (AUA)総会 Best of posters
  • 2006/11 - 第16回Society for Basic Urologic Research (SBUR)総会 トラベルアワード
Show all
Association Membership(s) (10):
Sigma Xi ,  Society for Basic Urologic Research ,  American Association for Cancer Research ,  泌尿器科分子・細胞研究会 ,  JAPANESE SOCIETY FOR CHEMICAL BIOLOGY ,  Japan Society of Endocrine Disrupter Research ,  JAPAN SOCIETY OF ANDROLOGY ,  THE JAPANESE SOCIETY OF PATHOLOGY ,  THE JAPANESE UROLOGICAL ASSOCIATION ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page